Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway

Cisplatin (DDP) is one of the first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC). However, repeated use of cisplatin in clinical practice often induces chemoresistance. The aims of this study were to investigate whether rosmarinic acid (RA) could reverse multidrug resistance (...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Xiao‐Zhong, Gao, Ying, Sun, Ling‐Ling, Liu, Jia‐Hui, Chen, Han‐Rui, Yu, Ling, Chen, Zhuang‐Zhong, Chen, Wen‐Hui, Lin, Li‐Zhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217221/
https://www.ncbi.nlm.nih.gov/pubmed/31985119
http://dx.doi.org/10.1002/ptr.6584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217221/
https://www.ncbi.nlm.nih.gov/pubmed/31985119
http://dx.doi.org/10.1002/ptr.6584

Ejemplares similares